Sevin Turcan - Related publications

Affiliations: 
Biomedical Engineering Tufts University, Boston 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Chang D, Shain AH. The landscape of driver mutations in cutaneous squamous cell carcinoma. Npj Genomic Medicine. 6: 61. PMID 34272401 DOI: 10.1038/s41525-021-00226-4   
2021 Chen J, Mai H, Chen H, Zhou B, Hou J, Jiang DK. Pan-Cancer Analysis Identified as a Potential Biomarker for Multiple Tumor Types. Frontiers in Molecular Biosciences. 8: 693651. PMID 34490347 DOI: 10.3389/fmolb.2021.693651   
2021 Han H, Jiang G, Kumari R, Silic MR, Owens JL, Hu CD, Mittal SK, Zhang GJ. Loss of smarcad1a accelerates tumorigenesis of malignant peripheral nerve sheath tumors in zebrafish. Genes, Chromosomes & Cancer. PMID 34296799 DOI: 10.1002/gcc.22983   
2021 Kong X, Yu D, Wang Z, Li S. Relationship between p53 status and the bioeffect of ionizing radiation. Oncology Letters. 22: 661. PMID 34386083 DOI: 10.3892/ol.2021.12922   
2021 Campeanu IJ, Jiang Y, Liu L, Pilecki M, Najor A, Cobani E, Manning M, Zhang XM, Yang ZQ. Multi-omics integration of methyltransferase-like protein family reveals clinical outcomes and functional signatures in human cancer. Scientific Reports. 11: 14784. PMID 34285249 DOI: 10.1038/s41598-021-94019-5   
2021 Campeanu IJ, Jiang Y, Liu L, Pilecki M, Najor A, Cobani E, Manning M, Zhang XM, Yang ZQ. Multi-omics integration of methyltransferase-like protein family reveals clinical outcomes and functional signatures in human cancer. Scientific Reports. 11: 14784. PMID 34285249 DOI: 10.1038/s41598-021-94019-5   
2021 Lawal B, Tseng SH, Olugbodi JO, Iamsaard S, Ilesanmi OB, Mahmoud MH, Ahmed SH, Batiha GE, Wu ATH. Pan-Cancer Analysis of Immune Complement Signature C3/C5/C3AR1/C5AR1 in Association with Tumor Immune Evasion and Therapy Resistance. Cancers. 13. PMID 34439277 DOI: 10.3390/cancers13164124   
2021 Andreassen PR, Seo J, Wiek C, Hanenberg H. Understanding BRCA2 Function as a Tumor Suppressor Based on Domain-Specific Activities in DNA Damage Responses. Genes. 12. PMID 34356050 DOI: 10.3390/genes12071034   
2021 Hua Y, Gao L, Li X. Comprehensive Analysis of Metabolic Genes in Breast Cancer Based on Multi-Omics Data. Pathology Oncology Research : Por. 27: 1609789. PMID 34408553 DOI: 10.3389/pore.2021.1609789   
2021 Wang Y, Peng J, Xie X, Zhang Z, Li M, Yang M. Gasdermin E-mediated programmed cell death: An unpaved path to tumor suppression. Journal of Cancer. 12: 5241-5248. PMID 34335940 DOI: 10.7150/jca.48989   
2021 Du C, Li SW, Singh SX, Roso K, Sun MA, Pirozzi CJ, Yang R, Li JL, He Y. Epigenetic regulation of Fanconi anemia genes implicates PRMT5 blockage as a strategy for tumor chemosensitization. Molecular Cancer Research : McR. PMID 34521764 DOI: 10.1158/1541-7786.MCR-21-0093   
2021 Sato A, Rahman NIA, Shimizu A, Ogita H. Cell-to-cell contact-mediated regulation of tumor behavior in the tumor microenvironment. Cancer Science. PMID 34420253 DOI: 10.1111/cas.15114   
2021 Ahn S, Grimes T, Datta S. The Analysis of Gene Expression Data Incorporating Tumor Purity Information. Frontiers in Genetics. 12: 642759. PMID 34497631 DOI: 10.3389/fgene.2021.642759   
2021 Huang L, Liu J, Zhu Y, Zhou Q, Xiao B, Sun Z, Li L. [The role of nuclear receptor transcription factor NR2F6 in tumor]. Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology. 37: 2595-2602. PMID 34472280 DOI: 10.13345/j.cjb.200488   
2021 Song L, Qi S, Hu W, Fang Z, Yu D, Liu T, Wu J, Wu Y, Wu A, Feng L, Xie J, Zhang B, He W, Ning Z, Liu L, et al. Integrative analysis reveals clinically relevant molecular fingerprints in pancreatic cancer. Molecular Therapy. Nucleic Acids. 26: 11-21. PMID 34513290 DOI: 10.1016/j.omtn.2021.06.015   
2021 Seo D, Roh J, Chae Y, Kim W. Gene expression profiling after LINC00472 overexpression in an NSCLC cell line. Cancer Biomarkers : Section a of Disease Markers. PMID 34397405 DOI: 10.3233/CBM-210242   
2021 Montazeri H, Coto-Llerena M, Bianco G, Zangene E, Taha-Mehlitz S, Paradiso V, Srivatsa S, de Weck A, Roma G, Lanzafame M, Bolli M, Beerenwinkel N, von Flüe M, Terracciano LM, Piscuoglio S, et al. Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screens. Nucleic Acids Research. PMID 34313788 DOI: 10.1093/nar/gkab627   
2021 Gu W, Yang J, Wang Y, Xu J, Wang X, Du F, Hu X, Guo H, Song C, Tao R, Zhang X. Comprehensive identification of alterations in 5 557 Chinese patients with solid tumors by next-generation sequencing. American Journal of Cancer Research. 11: 3893-3906. PMID 34522456   
2021 Marini F, Giusti F, Iantomasi T, Brandi ML. Genetic Determinants of Inherited Endocrine Tumors: Do They Have a Direct Role in Bone Metabolism Regulation and Osteoporosis? Genes. 12. PMID 34440460 DOI: 10.3390/genes12081286   
2021 Yi X, Zhou Y, Zheng H, Wang L, Xu T, Fu C, Su X. Prognostic targets recognition of rectal adenocarcinoma based on transcriptomics. Medicine. 100: e25909. PMID 34397867 DOI: 10.1097/MD.0000000000025909   
2021 Li T, Guan L, Tang G, He B, Huang L, Wang J, Li M, Bai Y, Li X, Zhang H. Downregulation of TMEM220 promotes tumor progression in Hepatocellular Carcinoma. Cancer Gene Therapy. PMID 34321624 DOI: 10.1038/s41417-021-00370-0   
2021 Li T, Guan L, Tang G, He B, Huang L, Wang J, Li M, Bai Y, Li X, Zhang H. Downregulation of TMEM220 promotes tumor progression in Hepatocellular Carcinoma. Cancer Gene Therapy. PMID 34321624 DOI: 10.1038/s41417-021-00370-0   
2021 Chen B, Xie X, Lan F, Liu W. Identification of prognostic markers by weighted gene co-expression network analysis in non-small cell lung cancer. Bioengineered. 12: 4924-4935. PMID 34369264 DOI: 10.1080/21655979.2021.1960764   
2021 Peri S, Biagioni A, Versienti G, Andreucci E, Staderini F, Barbato G, Giovannelli L, Coratti F, Schiavone N, Cianchi F, Papucci L, Magnelli L. Enhanced Vasculogenic Capacity Induced by 5-Fluorouracil Chemoresistance in a Gastric Cancer Cell Line. International Journal of Molecular Sciences. 22. PMID 34299320 DOI: 10.3390/ijms22147698   
2021 Liu J, Tian Z, Liu T, Wen D, Ma Z, Liu Y, Zhu J. CHSY1 is upregulated and acts as tumor promotor in gastric cancer through regulating cell proliferation, apoptosis, and migration. Cell Cycle (Georgetown, Tex.). 1-14. PMID 34412565 DOI: 10.1080/15384101.2021.1963553   
2021 Saleh A, Perets R. Mutated p53 in HGSC-From a Common Mutation to a Target for Therapy. Cancers. 13. PMID 34298679 DOI: 10.3390/cancers13143465   
2021 Chen CL, Meng E, Wu ST, Lai HF, Lu YS, Yang MH, Tsao CW, Kao CC, Chiu YL. Targeting May Result in Enhanced Migration of Cancer Cells in Bladder Carcinoma. Cancers. 13. PMID 34503284 DOI: 10.3390/cancers13174474   
2021 Xu Q, Xu H, Chen S, Huang W. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology. 9: 710207. PMID 34409040 DOI: 10.3389/fcell.2021.710207   
2021 Li G, Du X, Wu X, Wu S, Zhang Y, Xu J, Wang H, Chen T. Large-Scale Transcriptome Analysis Identified a Novel Cancer Driver Genes Signature for Predicting the Prognostic of Patients With Hepatocellular Carcinoma. Frontiers in Pharmacology. 12: 638622. PMID 34335239 DOI: 10.3389/fphar.2021.638622   
2021 Zerbib E, Arif T, Shteinfer-Kuzmine A, Chalifa-Caspi V, Shoshan-Barmatz V. VDAC1 Silencing in Cancer Cells Leads to Metabolic Reprogramming That Modulates Tumor Microenvironment. Cancers. 13. PMID 34200480 DOI: 10.3390/cancers13112850   
2021 Lothong M, Sakares W, Rojsitthisak P, Tanikawa C, Matsuda K, Yodsurang V. Collagen XVII inhibits breast cancer cell proliferation and growth through deactivation of the AKT/mTOR signaling pathway. Plos One. 16: e0255179. PMID 34293053 DOI: 10.1371/journal.pone.0255179   
2021 Noe O, Filipiak L, Royfman R, Campbell A, Lin L, Hamouda D, Stanbery L, Nemunaitis J. coli in cancer and therapeutic implications. Oncology Reviews. 15: 534. PMID 34267890 DOI: 10.4081/oncol.2021.534   
2021 Miro C, Nappi A, Cicatiello AG, Di Cicco E, Sagliocchi S, Murolo M, Belli V, Troiani T, Albanese S, Amiranda S, Zavacki AM, Stornaiuolo M, Mancini M, Salvatore D, Dentice M. Thyroid Hormone Enhances Angiogenesis and the Warburg Effect in Squamous Cell Carcinomas. Cancers. 13. PMID 34205977 DOI: 10.3390/cancers13112743   
2021 Kanwore K, Kambey PA, Guo XX, Abiola AA, Xia Y, Gao D. Extracellular and Intracellular Factors in Brain Cancer. Frontiers in Cell and Developmental Biology. 9: 699103. PMID 34513834 DOI: 10.3389/fcell.2021.699103   
2021 Liu Y, Xue J, Zhong M, Wang Z, Li J, Zhu Y. Prognostic Prediction, Immune Microenvironment, and Drug Resistance Value of Collagen Type I Alpha 1 Chain: From Gastrointestinal Cancers to Pan-Cancer Analysis. Frontiers in Molecular Biosciences. 8: 692120. PMID 34395525 DOI: 10.3389/fmolb.2021.692120   
2021 López V, Tejedor JR, Carella A, García MG, Santamarina-Ojeda P, Pérez RF, Mangas C, Urdinguio RG, Aranburu A, de la Nava D, Corte-Torres MD, Astudillo A, Mollejo M, Meléndez B, Fernández AF, et al. Epigenetic Deregulation of the Histone Methyltransferase Contributes to Malignant Transformation in Glioblastoma. Frontiers in Cell and Developmental Biology. 9: 671838. PMID 34447744 DOI: 10.3389/fcell.2021.671838   
2021 Padhye A, Konen JM, Rodriguez BL, Fradette JJ, Ochieng JK, Diao L, Wang J, Lu W, Solis LS, Batra H, Raso MG, Peoples MD, Minelli R, Carugo A, Bristow CA, et al. Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS mutant lung cancer. Jci Insight. PMID 34309585 DOI: 10.1172/jci.insight.148392   
2021 Zhan D, Ma D, Wei S, Lal B, Fu Y, Eberhart C, Laterra J, Ying M, Li Y, Meeker A, Lopez-Bertoni H, Xia S. Monoallelic IDH1 R132H mutation mediates glioma cell response to anti-cancer therapies via induction of senescence. Molecular Cancer Research : McR. PMID 34348994 DOI: 10.1158/1541-7786.MCR-21-0284   
2021 Cui G, Wang C, Lin Z, Feng X, Wei M, Miao Z, Sun Z, Wei F. Prognostic and immunological role of Ras-related protein Rap1b in pan-cancer. Bioengineered. 12: 4828-4840. PMID 34346294 DOI: 10.1080/21655979.2021.1955559   
2021 Mohanty V, Wang F, Mills GB, , Chen K. Uncoupling of gene expression from copy number presents therapeutic opportunities in aneuploid cancers. Cell Reports. Medicine. 2: 100349. PMID 34337565 DOI: 10.1016/j.xcrm.2021.100349   
2021 Wiechec E, Magan M, Matic N, Ansell-Schultz A, Kankainen M, Monni O, Johansson AC, Roberg K. Cancer-Associated Fibroblasts Modulate Transcriptional Signatures Involved in Proliferation, Differentiation and Metastasis in Head and Neck Squamous Cell Carcinoma. Cancers. 13. PMID 34283070 DOI: 10.3390/cancers13133361   
2021 Wiechec E, Magan M, Matic N, Ansell-Schultz A, Kankainen M, Monni O, Johansson AC, Roberg K. Cancer-Associated Fibroblasts Modulate Transcriptional Signatures Involved in Proliferation, Differentiation and Metastasis in Head and Neck Squamous Cell Carcinoma. Cancers. 13. PMID 34283070 DOI: 10.3390/cancers13133361   
2021 Park Y, Jung JG, Yu ZC, Asaka R, Shen W, Wang Y, Jung WH, Tomaszewski A, Shimberg G, Chen Y, Parimi V, Gaillard S, Shih IM, Wang TL. A novel human endometrial epithelial cell line for modeling gynecological diseases and for drug screening. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 34376780 DOI: 10.1038/s41374-021-00624-3   
2021 Su X, Xu Y, Fox GC, Xiang J, Kwakwa KA, Davis JL, Belle JI, Lee WC, Wong WH, Fontana F, Hernandez-Aya L, Kobayashi T, Tomasson HM, Su J, Bakewell SJ, et al. Breast cancer derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment. The Journal of Clinical Investigation. PMID 34520398 DOI: 10.1172/JCI145296   
2021 Pierce SE, Granja JM, Corces MR, Brady JJ, Tsai MK, Pierce AB, Tang R, Chu P, Feldser DM, Chang HY, Bassik MC, Greenleaf WJ, Winslow MM. LKB1 inactivation modulates chromatin accessibility to drive metastatic progression. Nature Cell Biology. PMID 34341533 DOI: 10.1038/s41556-021-00728-4   
2021 Duan L, Wang Z, Zheng X, Li J, Yin H, Tang W, Deng D, Liu H, Wei J, Jin Y, Liu F, Shen J. Excavating the pathogenic gene of breast cancer based on high throughput data of tumor and somatic reprogramming. Cell Cycle (Georgetown, Tex.). 1-15. PMID 34384323 DOI: 10.1080/15384101.2021.1961410   
2021 Touboul R, Zaravinos A, Bonavida B. Defective Natural Killer Cells in Melanoma: Role of NKG2D in Pathogenesis and Immunotherapy. Critical Reviews in Immunology. 41: 45-76. PMID 34348002 DOI: 10.1615/CritRevImmunol.2021037186   
2021 Hiltbrunner S, Mannarino L, Kirschner MB, Opitz I, Rigutto A, Laure A, Lia M, Nozza P, Maconi A, Marchini S, D'Incalci M, Curioni-Fontecedro A, Grosso F. Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma. Frontiers in Oncology. 11: 660039. PMID 34249695 DOI: 10.3389/fonc.2021.660039   
2021 Eke I, Aryankalayil MJ, Bylicky MA, Sandfort V, Vanpouille-Box C, Nandagopal S, Graves EE, Giaccia AJ, Coleman CN. Long-term expression changes of immune-related genes in prostate cancer after radiotherapy. Cancer Immunology, Immunotherapy : Cii. PMID 34435232 DOI: 10.1007/s00262-021-03036-w   
2021 Liu Y, Lou W, Chen G, Ding B, Kuang J, Zhang Y, Wang C, Duan S, Deng Y, Lu X. Genome-wide screening for the G-protein-coupled receptor (GPCR) pathway-related therapeutic gene (regulator of G protein signaling 19) in bladder cancer. Bioengineered. 12: 5892-5903. PMID 34482807 DOI: 10.1080/21655979.2021.1971035